Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 229

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cells

Open access
Yada, Toshihiko, Nakata, Masanori, Shiraishi, Tomoko, Kakei, Masafumi · 1999 · British Journal of Pharmacology

Abstract

Hypercholesterolaemia often occurs in patients with type 2 diabetes, who therefore encounter administration of HMG‐CoA reductase inhibitors. Alteration of pancreatic β‐cell function leading to an impaired insulin secretory response to glucose plays a crucial role in the pathogenesis of type 2 diabetes. Therefore, it is important to examine the effects of HMG‐CoA reductase inhibitors on β‐cell function. Cytosolic Ca 2+ concentration ([Ca 2+]i) plays a central role in the regulation of β‐cell function. The present study examined the effects of HMG‐CoA reductase inhibitors on the glucose‐induced [Ca 2+]i signalling and insulin secretion in rat islet β‐cells. Simvastatin, a lipophilic HMG‐CoA reductase inhibitor, at 0.1–3 μg ml−1 concentration‐dependently inhibited the first phase increase and oscillation of [Ca 2+]i induced by 8.3 m M glucose in single β‐cells. The less lipophilic inhibitor, simvastatin‐acid, inhibited the first phase [Ca 2+]i increase but was two orders of magnitude less potent. The hydrophilic inhibitor, pravastatin (100 μg ml−1), was without effect on [Ca 2+]i. Simvastatin (0.3 μg ml−1), more potently than simvastatin‐acid (30 μg ml−1), inhibited glucose‐induced insulin secretion from islets, whereas pravastatin (100 μg ml−1) had no effect. Whole‐cell patch clamp recordings demonstrated a reversible inhibition of the β‐cell L‐type Ca 2+ channels by simvastatin, but not by pravastatin. Simvastatin also inhibited the [Ca 2+]i increases by L‐arginine and KCl, agents that act via opening of L‐type Ca 2+ channels. In conclusion, lipophilic HMG‐CoA reductase inhibitors can inhibit glucose‐induced [Ca 2+]i signalling and insulin secretion by blocking L‐type Ca 2+ channels in β‐cells, and their inhibitory potencies parallel their lipophilicities. Precaution should be paid to these findings when HMG‐CoA reductase inhibitors are used clinically, particularly in patients with type 2 diabetes. British Journal of Pharmacology (1999) 126, 1205–1213; doi:10.1038/sj.bjp.0702397

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0702397

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Yada, T., Nakata, M., Shiraishi, T., & Kakei, M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1999-03
Volume
126
Issue
5
Pages
1205-1213
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2033932529
Cited by
229
References
8
FWCI
2.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.